Fidelity Investments
PRVA icon

Fidelity Investments’s Privia Health PRVA Stock Holding History

Fidelity Investments’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331M Sell
12,848,437
-197,105
-2% -$4.57M 0.01% 717
2026
Q1 		$268M Buy
13,045,542
+995,493
+8% +$22.4M 0.01% 737
2025
Q4 		$286M Sell
12,050,049
-414,482
-3% -$10.1M 0.01% 722
2025
Q3 		$310M Sell
12,464,531
-1,514,303
-11% -$32.6M 0.02% 680
2025
Q2 		$322M Sell
13,978,834
-3,981,833
-22% -$92.2M 0.02% 646
2025
Q1 		$403M Sell
17,960,667
-247,534
-1% -$5.75M 0.03% 536
2024
Q4 		$356M Buy
18,208,201
+39,158
+0.2% +$776K 0.02% 593
2024
Q3 		$331M Buy
18,169,043
+271,645
+2% +$5.18M 0.02% 626
2024
Q2 		$311M Buy
17,897,398
+1,587,815
+10% +$28.1M 0.02% 624
2024
Q1 		$320M Buy
16,309,583
+463,449
+3% +$9.79M 0.02% 600
2023
Q4 		$365M Buy
15,846,134
+1,574,205
+11% +$35.2M 0.03% 524
2023
Q3 		$328M Sell
14,271,929
-495,926
-3% -$12.6M 0.03% 530
2023
Q2 		$386M Buy
14,767,855
+13,072,807
+771% +$345M 0.03% 491
2023
Q1 		$46.8M Buy
1,695,048
+349,326
+26% +$9.22M ﹤0.01% 1286
2022
Q4 		$30.6M Sell
1,345,722
-97,969
-7% -$2.73M ﹤0.01% 1456
2022
Q3 		$49.2M Sell
1,443,691
-13,223
-0.9% -$489K 0.01% 1250
2022
Q2 		$42.4M Buy
1,456,914
+640,492
+78% +$16.3M ﹤0.01% 1343
2022
Q1 		$21.8M Buy
816,422
+227,922
+39% +$5.38M ﹤0.01% 1744
2021
Q4 		$15.2M Sell
588,500
-12,725
-2% -$317K ﹤0.01% 1949
2021
Q3 		$14.2M Sell
601,225
-7,275
-1% -$254K ﹤0.01% 1978
2021
Q2 		$27M Buy
+608,500
New +$22.5M ﹤0.01% 1710

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments's PRVA Position: Q2 2026 in Review

Fidelity Investments reduced its Privia Health (PRVA) stake by 1.5% in Q2 2026, selling an estimated $4.57M and leaving 12,848,437 shares worth $331M. The position accounts for 0.01% of the portfolio, ranked #717.

Fidelity Investments first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $403M in Q1 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Fidelity Investments held 12,848,437 shares of Privia Health worth $331M as of Q2 2026.
  • Fidelity Investments sold 197,105 Privia Health shares in Q2 2026, an estimated $4.57M.
  • Privia Health made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #717 holding.
  • Fidelity Investments first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Privia Health position peaked at $403M in Q1 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.